Companies

4MindHealth delivers consumer-focused mental health solutions through hard technology and innovative service models. We are building an ecosystem that bridges easily approachable, even exciting, biomarkers and behavioural nudges on the mobile with digital care delivery. Our business models thrives on a combination of data volume from our Asian target markets and clinical expertise from our Finnish home base.

AarogyaAI’s vision is to make precision diagnosis for antimicrobial resistance accessible at the point of care by harnessing the powers of genomics and artificial intelligence. The aim is to reduce the incidence and spread of antimicrobial-resistant infections and stay one step ahead of the bugs! AI helps unearth future drug resistance patterns to preemptively plan actions and combat the next pandemic.

PALL0 by Ai2Ai is a sensor-packed interactive ball with AI and unlimited apps. The product boosts physical and social activities for wellness seekers and reduces screen time.

Aistin Technologies brings 21st-century technology to blind people around the globe. Using the company's smart cane, blind and visually impaired people can independently move around without unnecessary risks of injuries or getting lost.

No more trial-and-error research. AnalysisMode offers online Laboratory Environment Simulators, helping scientists to design experiments and predict failure. From cell-culture simulation to OMICS predictors, the scientists using AnalysisMode reduce their research time, being able to perform a 1-week experiment in just 1-hour, saving 700 hours per year and yielding 5x more discoveries. AnalysisMode tailors its simulators to each customer.

Ankerias provides healthcare professionals a digital platform that enhances the treatment of chronic pain patients. Using pain diary app, data analysis, AI/ML and physiological modelling Ankerias personalizes and targets spinal cord stimulation (SCS) pain therapy. Ankerias brings together a unique combination of expertise in the physiology of the pain and artificial intelligence. Our passion is to fuse these with cutting-edge technology to create a game-changing healthcare solution for chronic pain.

Cardiolyse provides a chronic and post-discharge cardiovascular disease patient monitoring platform with medical-grade AI heart health analytics (CE class 2a, 19 arrhythmias) that enables remote vital sign monitoring and personalized patient reports for early diagnostics and better care.

Cardiomtec is a Finnish 2020 founded corporation holding more than 20 years of experience of developing medical devices. Cardiomtec specializes in developing applications and portable devices for wellbeing technology. Cardiomtec products are affordable, small and reliable. With Cardiomtec devices one can measure and evaluate cardiac function of an individual at home environment, data is uploaded to a cloud server from where a medical doctor can review it with web-portal.

ClickPET offers technical solutions for simplifying the production of disease specific biomolecule-based radiopharmaceuticals for positron emission tomography (PET) for aiding patient selection, cancer staging and disease follow-up by diagnostic imaging. The company's technology enables the speeding-up of new radiotracer development facilitating the discovery of new diagnostic methods for personalized medicine.

CorFlux aims to be the world’s leading analyzing software for estimating the risk of aortic aneurysm rupture. The current clinical method does not take into account other influencing elements than the aortic diameter in the risk evaluation. However, a high number of aortic ruptures appear before the diameter reaches the limit for surgery. CorFlux decision-making support allows physicians to identify high-risk aneurysm patients more easily, leading to life savings.

Corle is developing a small wireless medical device for the diagnostic and monitoring purposes of sleep apnea. The patented solution is a non-invasive optical sensor for continuous medical grade health data collection from the earlobe, sending the data via Bluetooth to a mobile phone application for analysis and sharing.

CurifyLabs is set to transform personalized drug manufacturing through its digital and automated TailoredCure technology. We offer a Medicine as a Service concept for pharmacies, hospital pharmacies and veterinarians which saves time, delivers better and sustainable future treatments to pets and humans.​

Eipha Biosciences is developing a dissolvable microneedle patch that delivers a proprietary blend of natural active ingredients directly into the skin. This painless technology bypasses the skin’s barrier to target vitiligo at its source, offering a safer, easier patient experience than existing treatments. Early lab models show encouraging repigmentation results, positioning Eipha as an innovative player in dermatological biotechnology. The company aims to enhance vitiligo care and expand into other skin conditions.

EpiHeart is a young medical device company focused on enabling Cardiac Micrograft Therapy™, an adjuvant therapy administered during cardiac interventions such as coronary artery bypass grafting surgery. Cardiac Micrograft Therapy™ is a novel therapy for treating ischemic injury and consequent ischemic scars and heart failures. The company is focused on the development and commercialization of medical device packages to enable the therapy and it aims to drive the therapy into mainstream clinical use. The first-in-man clinical trial has already been completed in academic setting. The company is a spin-out from the University of Helsinki and the HUS Helsinki University Hospital.

EsaDres was founded by the University of Tartu researchers in 2023. EsaDres provides personalized solution for the treatment of chronic wounds by preparing customised high-quality wound dressings for patients in clinics on-demand. Their technology and manufacturing will be automated, validated to achieve the high manufacturing standards at the point of care and the method enables production of various wound dressings according to the needs.

Evexia encourages patient-oriented healthcare through building a new digital solution for cancer care. Alas, no solution exists in helping doctors determine objectively the physical condition of the patient. Evexia’s mobile application, data analysis and clinical dashboard allows doctors to make better and more objective care decisions for patients and thus make cancer care better for all involved.

Fepod Oy Ltd is revolutionizing point-of-care diagnostics with a cutting-edge IVD technology platform that enables real-time measurement of pain medication and other biomarkers from just a drop of blood. Our innovative solution combines a fast, simple, and minimally invasive sampling process with instant results, utilizing a mobile phone, a portable reader, and mass-producible disposable sensors. This breakthrough technology empowers healthcare providers with accurate, on-the-spot diagnostics, improving patient care and treatment decisions.

Finnadvance is bridging the gap between in-vitro and in-vivo research with its microfluidic organ-on-chips for pharmaceutical drug research and development. With industry leading high throughput microphysiological culture platforms, complex in vivo biomechanical cues are mimicked on the in vitro cultures.

Flux Polymers produces a hydrophilic polymer that can be spray or dip coated onto plastic surfaces and permanently linked by UV-irradiation. The patented coating prevents the attachment and growth of bacteria. The antibacterial effect of the coating is based on a purely physical effect, so that no toxic substances are released that could cause resistance in bacteria. The process is fast, cost efficient and not detrimental to the used material.

Hoivita Oy offers innovative remote monitoring solutions for home care providers, assisted living units, and seniors living at home. Our wireless, non-wearable sensors are easy to install and automatically integrate into the IoT network, enabling cost-effective and reliable remote monitoring. Our solutions extend the time seniors can live at home and ensure a safe environment both at home and in care facilities.

Innofend is a biotech spin-off from Tampere University developing next-generation vaccines against pandemic viruses. Our lead product is a proprietary enterovirus platform using virus-like particles (VLPs). Our technology can safely and efficiently generate protective immune responses, even against viruses that can’t be targeted using traditional methods. We’re combining innovative science with scalability to close critical gaps in vaccine development.

Lapsi Health is developing the new generation of digital biomarkers based on auscultatory sound. The data used as a biomarker has to be quantifiable and objective and the company’s novel technology greatly enhances its usage in medicine, relating it to the health-disease process for prognostic, diagnostic and therapeutic purposes.

Maculaser develops novel medical technology for treatment of common retinal diseases, including diabetic macular edema and dry age-related macular degeneration. The core of the company’s innovation is the precise temperature control of the macula during non-damaging laser treatments; a potential game changer in the practice how retinal diseases, with over 200B EUR direct health care costs, are being treated in the future.

MedicubeX is developing a self-check station with several disruptive health measurements and remote appointment technology. The measurement station allows for the individual the measurement of their own vital signs and novel noninvasive cardiovascular risk factors. End users are not only patients, but also healthy individuals looking for their personal health status and early signs of potential diseases. The station’s soundproofing maintains privacy while cutting-edge sterilization technology keeps the station clear of microbes and viruses.

Medified is transforming mental health treatments with data-driven monitoring software. Software develops a dynamic and secure connection between patients and healthcare professionals to create a more extensive overview of the patient personal recovery process. The company’s SaaS is designed to improve the intensity of mental health treatment and enable digital healthcare services.

Mediverse functions as a crucial component of the conventional healthcare system, operating as a telemedicine platform that incorporates advanced technology and intelligent biosensors. As a result, patients can receive remote medical consultations, diagnoses, and treatments in a timely manner, irrespective of their location.

Mind’s Eye is accelerating eye-tracking diagnostics. Mind´s Eye develop optimal and comprehensive eye-tracking solutions for large-scale screening trials. Mind’s Eye empowers individuals with affordable yet scientific-grade eye tracking at home to help identify deficits and guide interventions.

MONCYTE Health is developing pioneering technology that provides quantitative insight into the biological processes that give rise to high blood cholesterol and how they are different in individuals. MONCYTE Health provides new data for clinical use and enables novel readouts for pharmaceutical companies developing lipid-lowering treatments.

MultivisionDx aims to transform personalized diagnosis and treatment selection for cancer patients. The MultivisionDx computer vision workflow analyzes images of tumor biopsies, generating patient-specific tumor profiles describing the unique biology of each patient's disease. This approach enables clinicians to assess tumor aggressiveness and tailor treatment strategies for individual patients.

The biology and key role of NAD molecules in human metabolism has been well known for decades, but measuring them has been devilishly difficult. NADMED has now brought to market an accurate, fast, scalable, and well protected method to do just that. The assay enables research in large human cohorts, leading to a rapidly increasing number of clinical applications. NADMED already services clinical practitioners, researchers and drug development companies.

Natal Mind is a revolutionary, AI-powered birth coach and perinatal mental health support for both parents, always available on their mobile phones. The virtual coach, Natalie follows the Nordic Method: Clinically validated journey to better birth and calmer parenthood. Natalie is following an emotion tracking algorithm developed and tested in Aalto University and connected with wearable data, offering personalised excercises and a future biomarker for perinatal mental health.

Nordic Fit Mama is a Finnish company that offers online wellness training for mothers. An award winning, 6-week Post Natal Program helps women to recover post-baby body in a safe way with the support of trained professionals. Nordic Fit Mama also offers a program for pregnant women and another one for more intensive training. All exercises are medically approved and recommended by gynecologists, midwives and physiotherapists. In September 2020 Nordic Fit Mama launched its first program for women in menopause.

Olo empowers mindful exploration of self, community, and nature through personalized digital experiential learning that incorporates immersive listening and embodiment practice with real-time biofeedback and community support in a mobile app experience. Built on the foundation of neuroscience research and AI-powered technology, Olo’s app uniquely responds to the prolific mental health and stress management needs of each individual user.

Otos is shaping the future with early and profitable hearing care. Their first product is a system to help overburdened hearing clinics eliminate and automate cumbersome and costly hearing health diagnosis procedures. This can be done by maintaining or improving the quality of the results, increasing patient throughput, bringing cost-effectiveness, and improving profitability.

Probiont is developing personalized solutions for cancer immunotherapy efficacy testing. Our technology is purposed to enable rapid screening of cancer drugs used in immunotherapy, for early identification of effective treatment strategies for individual patients.

R2therapies Oy has discovered a novel and scientifically surprising blood-based biomarker to identify people at risk of developing dementia. The company aims to to develop an in-vitro diagnostic method compatible with primary healthcare for dementia-risk screening.

RoboMed has innovated a robotic capsule for endoscopy, biopsy and microbiota sampling of the small intestine to diagnose, predict and prevent diseases and disorders with a minimally invasive method. The robotic capsule is working in real-time mode and communicating via a smartphone application while streaming live images and equipped with biopsy needles to perform sampling of small intestine. Taken samples will be carried out of the body for further examination as well as pathology to diagnose and prevent cancers, diseases and disorders.

Ronroo is a psychoeducation app that offers easy-to-reach support for people with self-control and executive functioning difficulties. Rather than a habit tracker or task manager, it teaches users skills and strategies with personalized learning pathways that adapt to users' values and circumstances. Developed by a team of experts who are themselves neurodivergent, Ronroo is a research-based support system that makes self-regulation accessible for all.

Sartar Therapeutics revolutionizes sarcoma therapy. There is an urgent clinical need to find efficacious sarcoma therapies. Sartar Therapeutics is a preclinical stage biotech company that will meet the need by developing precision medicine products to treat rare cancers. The first product candidate SAR001 is based on Sartar’s repurposed, proprietary reformulated anagrelide. SAR001 is a controlled-release anagrelide product that targets PDE3A protein that is highly expressed in sarcomas such as gastrointestinal stromal tumor, liposarcoma and other soft tissue sarcomas.

SCellex develops novel solutions for spatial single cell gene sequencing analyses with patented coloured microbeads on picowell arrays. The method works in various applications and is suitable both for tissue cryosections and cell suspensions, allowing also functional high throughput cell assays and single cell cultures in picowells. The method helps biomedical researchers to discover the locations, roles and interactions of different cell types both in healthy tissues and diseases, and to explore their key marker genes as potential drug targets.

Scopia is a Finnish digital health startup turning colonoscopy quality data into real time insight to prevent colorectal cancer, the world’s second deadliest cancer. Its cloud platform records key procedure details in seconds and displays live dashboards so clinicians can raise adenoma detection rates and eliminate the 7 % of cancers that slip through sub optimal exams. Already deployed in Finnish hospitals with full GDPR compliance, Scopia lets endoscopy teams focus on patients while the software quietly lifts the bar on quality.

SeeTrue Technologies develops the world’s most robust eye-tracking solutions and integrates them with manufacturers of vision care, optical microscopes, and AR/VR devices. The significance of eye tracking has surged, making it an indispensable technology for intelligent interactive systems that understand, predict, and react to human behavior. Their approach, crafted by a team of experienced tech professionals, stands out for its small footprint, exceptional robustness, computational efficiency, minimal compute requirements, and versatile deployment on any hardware, distinguishing it from methods relying solely on machine learning predictions. This empowers customers to unlock new insights, offer personalized solutions, and make a profound impact on society.

SOENIAⓇ by BrainCare is a Tampere University of Technology spin-off company founded in 2013. The mission is to offer remote long-term monitoring solutions to improve the quality of life of neurological patients with a special focus on epilepsy. The company offers a novel mobile application and supporting solutions for digital symptom tracking to better monitor and understand the conditions of each patient. Both the app and the implant send their data directly to the patient’s doctor via secure cloud platform, SOENIA® Cloud. Patient-generated data from the SOENIA® Medical Diary app is shown alongside the EEG activity, which helps doctors plan and provide better treatments. CE-marked SOENIA® Medical Diary application and SOENIA® Cloud were piloted and evaluated in clinical trials at the Tampere University Hospital.

Solid-IO is revolutionizing cancer care by eliminating guesswork and enhancing accessibility to immunotherapy drugs with a scalable and fast solution. Through the miniaturization of a patient’s tumor and immune cells in distinctive organ-on-a-chip assays, Solid-IO recreates an individual’s specific antitumor immunity. This empowers oncologists to make informed decisions when choosing personalized treatments for their patients.

An easy-to-use HeartScan providing immediate heart failure detection, superior heart sound analysis and enhanced efficiency.

Surgerix is the future of microsurgery. Surgerix is developing and pre-commercializing a medical device software solution. Their project is a spin-off from University of Eastern Finland and Kuopio University Hospital Microsurgery Center.

Uoma is the first AI-powered narrative therapy app designed to help individuals struggling with stress, anxiety, and emotional challenges. Unlike traditional mental health apps, Uoma transforms users’ spoken reflections into personalized therapeutic stories, helping them reframe their struggles, gain clarity, and track their emotional growth over time. Available 24/7, Uoma provides a private, structured, and engaging way to process emotions—making therapy more accessible, reflective, and empowering.

Uute Scientific drives for “Life without immune-mediated diseases”, such as diabetes 1, allergies and asthma. These immune-mediated diseases are caused by our modern and urban lifestyle. Our move away from nature with its microbial diversity has made our immune system weaker. Uute has patent pending substance, which brings that natural microbial diversity back to people and help them in the development of a strong immune system. Uute will be available to people through consumer product companies.

VEIL.AI is a spin-out from FIMM (Institute for Molecular Medicine Finland). The company wants to enable discoveries for better health; it enables utilization of sensitive health data for new discoveries and better decision making in healthcare. VEIL.AI specializes in health data anonymization services and synthetic data. The unique technology helps healthcare actors to utilize sensitive data in ways that were not possible before – combine, analyze and share sensitive data more securely, efficiently and with richer quality.

Viseur AI supports the AI transformation in the healthcare sector by providing an all-in-one / no-code artificial intelligence development ecosystem (SaaS) in the field of medical imaging. It offers services that enable healthcare professionals to develop their own AI products for diagnostic and therapeutic purposes in radiology and digital pathology, and to utilize these products in their clinical environments.